BHST BioHarvest Sciences Inc. - Common Stock
NASDAQ · Consumer products · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 31, 2026
$1.47
· of 52w range
· above low
· to high
$1.4252w low
$12.8052w high
Revenue
$35M
your badges
52W Range
$1–$13
Analyst Rating
BUY
Price Target
$10
P/E
·
ROE
-83.2%
Net Profit Margin
-32.3%
Your badge strip is empty — pin a metric anywhere on this page.
BHST Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.47
Revenue
$35M
ROE
-83.2%
Debt/Equity
0.0
52W Range
$1–$13
BHST Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$35M2023-12-31 → 2025-12-31
Free Cash Flow$-10M2024-12-31 → 2025-12-31
Net margin-32.3%2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | BHST | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 59.3% | · | · | · | |
| Operating Margin | -16.2% | · | · | · | |
| EBITDA Margin | -11.5% | · | · | · | |
| Pretax Margin | -32.0% | · | · | · | |
| Net Profit Margin | -32.3% | · | · | · | |
| ROA | -30.6% | · | · | · | |
| ROE | -83.2% | · | · | · | |
| ROIC | -21.6% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BHST | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | · | · | · | |
| Current Ratio | 4.0 | · | · | · | |
| Quick Ratio | 3.3 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | BHST | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.9 | · | · | · | |
| Inventory Turnover | 3.4 | · | · | · | |
| Receivables Turnover | 22.3 | · | · | · | |
| Revenue / Employee | ≈$387.7K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.2%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| March 31, 2025 | $-0.13 | $-0.12 | -4.5% | |
| Dec. 31, 2024 | $-0.17 | $-0.16 | -7.4% | |
| Sept. 30, 2024 | $-0.10 | $-0.07 | -43.9% | |
| June 30, 2024 | $-0.06 | $-0.14 | 60.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $35M | $25M | $13M | |
| Cost of Revenue | $14M | $11M | $7M | |
| Gross Profit | $20M | $14M | $6M | |
| R&D Expense | $5M | $5M | $3M | |
| SG&A Expense | $5M | $4M | $4M | |
| Operating Expenses | $26M | $21M | $16M | |
| Operating Income | $-6M | $-7M | $-10M | |
| Pretax Income | $-11M | $-13M | $-13M | |
| Income Tax | $-76.0K | $-8.0K | $0 | |
| Net Income | $-11M | $-13M | $-13M | |
| EPS (Basic) | $-0.60 | $-0.80 | $-0.93 | |
| EBITDA | $-4M | $-6M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $23M | $2M | $5M | |
| Receivables | $2M | $1M | $808.0K | |
| Inventory | $5M | $4M | $2M | |
| Current Assets | $30M | $8M | $9M | |
| PP&E (Net) | $8M | $8M | $4M | |
| PP&E (Gross) | $11M | $10M | $6M | |
| Accum. Depreciation | $2M | $2M | $2M | |
| Total Assets | $48M | $25M | $15M | |
| Accounts Payable | $3M | $4M | $2M | |
| Accrued Liabilities | $386.0K | $401.0K | $458.0K | |
| Short-term Debt | $149.0K | $4M | $0 | |
| Current Liabilities | $8M | $14M | $26M | |
| Other Non-current Liabilities | $2M | $272.0K | $2M | |
| Total Debt | $149.0K | $4M | · | |
| Paid-in Capital | $133M | $98M | $69M | |
| Retained Earnings | $-108M | $-96M | $-84M | |
| Stockholders' Equity | $25M | $1M | $-15M | |
| Liabilities + Equity | $48M | $25M | $15M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $1M | $840.0K | |
| Deferred Tax | $0 | $0 | $0 | |
| Other Non-cash | $2M | $5M | · | |
| Operating Cash Flow | $-7M | $-7M | $-9M | |
| CapEx | $2M | $3M | $1M | |
| Investing Cash Flow | $-2M | $-3M | $-1M | |
| Stock Issued | $18M | $0 | $0 | |
| Net Stock Activity | $18M | $4M | · | |
| Financing Cash Flow | $30M | $7M | $14M | |
| Net Change in Cash | $21M | $-3M | $4M | |
| Taxes Paid | $39.0K | $45.0K | · | |
| Free Cash Flow | $-10M | $-10M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Gross Margin | 59.3% | 55.4% | · | |
| Operating Margin | -16.2% | -27.8% | · | |
| Net Margin | -32.3% | -51.3% | · | |
| Pretax Margin | -32.0% | -51.2% | · | |
| EBITDA Margin | -11.5% | -22.8% | · | |
| ROA | -30.6% | -64.6% | · | |
| ROE | -83.2% | 191.0% | · | |
| ROIC | -21.6% | -133.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 4.0 | 0.6 | · | |
| Quick Ratio | 3.3 | 0.2 | · | |
| Debt / Equity | 0.0 | 2.9 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.3 | · | |
| Inventory Turnover | 3.4 | 3.7 | · | |
| Receivables Turnover | 22.3 | 26.2 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $35M | $25M | · | |
| Net Income TTM | $-11M | $-13M | · |
No quarterly filings for BHST
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Revenue | $35M | $25M | $13M |
| Gross Margin % | 59.3% | 55.4% | · |
| Operating Margin % | -16.2% | -27.8% | · |
| Net Income | $-11M | $-13M | $-13M |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Debt / Equity | 0.0 | 2.9 | · |
| Current Ratio | 4.0 | 0.6 | · |
| Quick Ratio | 3.3 | 0.2 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | $-10M | $-10M | · |
Institutional owners (13F) 19 filers · $3.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
19
Value held
$3.8M
New positions
2
Exited positions
3
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (0 vs prior Q) | 3 (-1 vs prior Q) | 6 (+2 vs prior Q) | 7 (+2 vs prior Q) | -18K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | $1,662,921 | 581,441 | 44.19% | Shares |
| Evercore Wealth Management, LLC | $618,741 | 216,343 | 16.44% | Shares |
| True North Advisors, LLC | $535,729 | 187,318 | 14.24% | Shares |
| Magnus Financial Group LLC | $257,400 | 90,000 | 6.84% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $179,516 | 63,658 | 4.77% | Shares |
| Silverberg Bernstein Capital Management LLC | $162,779 | 57,723 | 4.33% | Shares |
| KING LUTHER CAPITAL MANAGEMENT CORP | $114,400 | 40,000 | 3.04% | Shares |
| TD Waterhouse Canada Inc. | $65,525 | 23,827 | 1.74% | Shares |
| CITADEL ADVISORS LLC | $58,239 | 20,652 | 1.55% | Shares |
| XTX Topco Ltd | $37,314 | 13,232 | 0.99% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $29,773 | 10,558 | 0.79% | Shares |
| K.J. Harrison & Partners Inc | $27,892 | 10,000 | 0.74% | Shares |
| MORGAN STANLEY | $9,295 | 3,250 | 0.25% | Shares |
| OSAIC HOLDINGS, INC. | $1,633 | 571 | 0.04% | Shares |
| THOMPSON SIEGEL & WALMSLEY LLC | $1,041 | 364,008 | 0.03% | Shares |
| UBS Group AG | $495 | 173 | 0.01% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $423 | 154 | 0.01% | Shares |
| Caitong International Asset Management Co., Ltd | $6 | 2 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 9 | 0.00% | Shares |
BHST Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 8 analysts
BUY
Median target
$11.00
+648.3%
2 25.0%
Strong Buy
5 62.5%
Buy
1 12.5%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
4 analysts · 2026-10-04Mean target $10.50 +614.3%
← Below all targets
Current price $1.47
Low$5.00
Mean$10.50
High$15.00
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 40-F filed Mar 31, 2026